Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IMMUNIC, INC. (VTL)
|
Add to portfolio |
|
|
|
| Price: |
$14.23
| | Metrics |
| OS: |
44.6
|
M
| |
|
|
| Market cap: |
$635
|
M
| |
|
|
|
Net cash:
|
$77.3
|
M
| |
$1.73
|
per share
|
|
EV:
|
$557
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| Revenue growth | | | | | | | -100.0% | 3.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | 0.0% |
| Research and development | 71.3 | 61.1 | 38.6 | 22.5 | 9.6 | 39.3 | 30.0 | 39.8 |
| General and administrative | 15.3 | 13.3 | 10.3 | 14.5 | 2.4 | 13.3 | 11.2 | 12.3 |
| EBIT | -86.5 | -91.7 | -49.0 | -37.0 | -12.0 | -52.7 | -41.3 | -52.1 |
| EBIT margin | | | | | | | | -6046.4% |
| Pre-tax income | -120.4 | -92.9 | -44.0 | -34.9 | -11.5 | -52.1 | -41.0 | -52.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -120.4 | -92.9 | -44.0 | -34.9 | -11.5 | -52.1 | -41.0 | -52.0 |
| Net margin | | | | | | | | -6035.2% |
| |
| Diluted EPS | ($3.78) | ($3.93) | ($2.81) | ($4.52) | ($13.63) | ($1.31) | ($1.31) | ($2.07) |
| Shares outstanding (diluted) | 31.8 | 23.7 | 15.7 | 7.7 | 0.8 | 39.9 | 31.4 | 25.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|